CoChat

Improved short- and long-term XTT-based colorimetric cellular cytotoxicity assay for melanoma and other tumor cells

Jost, L.M., Kirkwood, J.M., Whiteside, T.L. · 1992 · Journal of Immunological Methods

The DOI matches its Crossref record; 22 of the 23 references it cites were found in a registry or an index.

Abstract

A tetrazolium compound, XTT, bioreducible to a water-soluble formazan was used to develop a simplified cellular cytotoxicity assay. Most (13/15 melanoma and 2/3 colon carcinoma cell lines tested metabolized XTT greater than 50 times more efficiently than the lymphoid effector cells, and thus the test could be performed without separation of the effector from the target cells. The XTT assay (XTT-A) was compared to the standard 51chromium-release assay (51CrA) in terms of sensitivity as well as intra- and interassay variability using low effector to target cell (E:T) ratios and both short and long incubation periods. The correlation coefficient (r) for percent specific lysis (%SL: 35.0 +/- 15.0 versus 30.2 +/- 15.8) or lytic units (LU20/10(7) effector cells: 405 +/- 208 versus 357 +/- 227) between XTT-A and 51CrA was 0.86 for 4 h XTT-A and 51CrA (n = 37). Due to a poor performance of the 51CrA after 24 h incubation of effector and target cells, the correlation coefficient for 24 h assays was reduced to 0.79 (n = 44,%SL = 63.3 +/- 23.9 versus 55.5 +/- 26.6, and LU = 1267 +/- 982 versus 1017 +/- 691). Inter- and intra-assay variability of XTT-A were significantly lower than those for 51CrA. The total background values for XTT-A and 51CrA were similar in 4 h cytotoxicity assay and lower for XTT-A in assays with 24 h incubation. The sensitivity, in terms of discrimination between effector cells with different lytic capacity and targets with different susceptibility, was identical.…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0022-1759(12)80003-2

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 22 references

Research works printed but not linked: 1

  1. Vistica, 1989, Tetrazolium-based assays for cellular viability: A critical examination of parameters which affect formazan production [abstract], Proc. Am. Assoc. Cancer Res., 30, 612

Cited by

See all 185

Metadata

Authors
Jost, L. M., Kirkwood, J. M., & Whiteside, T. L.
Affiliations
University of Pittsburgh (US)
Corresponding author
Jost, L.M.
Venue
Journal of Immunological Methods
Publisher
Elsevier BV
Published
1992-03
Volume
147
Issue
2
Pages
153-165
ISSN
0022-1759 (ISSN-L)
OpenAlex
W2062932184
Cited by
182
References
23
Citations by year
2026: 1 · 2025: 2 · 2024: 7 · 2023: 7 · 2021: 1 · 2020: 2 · 2019: 6 · 2018: 2 · 2017: 5 · 2016: 10 · 2015: 6 · 2014: 7 · 2013: 9 · 2012: 7
FWCI
0.95
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Journal of Immunological Methods (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
Keywords
XTT, melanoma, tumor cell killing, 51Cr release assay, effector-to-target ratio, assay sensitivity, assay variability, tumor cell lysis
MeSH terms
Adenocarcinoma, Chromium Radioisotopes, Colonic Neoplasms, Colorimetry, Cytotoxicity Tests, Immunologic, Humans, Indicators and Reagents, Killer Cells, Natural, Melanoma, Sensitivity and Specificity, Tetrazolium Salts, Tumor Cells, Cultured, Reproducibility of Results, Killer Cells, Lymphokine-Activated

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Improved short- and long-term XTT-based colorimetric cellular cytotoxicity assay for melanoma and other tumor cells. https://app.cochat.ai/papers/10.1016/s0022-1759(12)80003-2
The paper
Jost, L. M., Kirkwood, J. M., & Whiteside, T. L. (1992). Improved short- and long-term XTT-based colorimetric cellular cytotoxicity assay for melanoma and other tumor cells. Journal of Immunological Methods. https://doi.org/10.1016/s0022-1759(12)80003-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.